Two women have won the Nobel prize in chemistry for the development of the revolutionary CRISPR/Cas9 gene editing tool that’s been described as “rewriting the code of life.” ...

Crispr’s early pioneers founded three companies with exclusive licenses to exploit Crispr/Cas9 to cure human diseases; one of them began its first human trials in early 2019.

The newly discovered anti-CRISPR proteins — which are the first to work against the type of CRISPR-Cas9 system most commonly used by laboratories and the burgeoning gene editing industry — could help ...

Type 2 system is somewhat unique in comparison to the other CRISPR-Cas systems, since only one Cas protein is actually needed for gene silencing – this is the Cas9 protein.

They revealed that Cas9, short for CRISPR-associated endonuclease 9, acts like a scissors, snipping DNA. The two women earned a Nobel Prize in chemistry in 2020 for their findings.

Biomedical engineers have used a CRISPR/Cas9 genetic engineering technique to turn off a gene that regulates cholesterol levels in adult mice, leading to reduced blood cholesterol levels and gene ...

Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing. Science Advances, 2022; 8 (42) DOI: 10.1126/sciadv.abo7676; ...

Since it burst onto the scene a decade ago, CRISPR-Cas9 has shaken the field of genetics to its core with a genome editing tool that’s faster, cheaper and more accurate than previous methods.

CRISPR-Cas9 genome editing has revolutionized the food and medicine industries. The method involves introducing Cas9 nuclease—an enzyme that cuts DNA—into cells, with a synthetic guide RNA ...

Discover how CRISPR-Cas9 technology is revolutionizing spider silk production with red fluorescent fibers and advancing genetic research.